Energy Efficiency, GHG Emissions, Industrial - July 11, 2024
BD Surpasses Scope 1 & 2 Goals
BD (Becton, Dickinson and Company), a global medical technology company, announced it has surpassed its Scope 1 and 2 science-based GHG emissions reduction targets for FY 2023 by 5 percentage points and received approval for near- and long-term science-based emissions reduction targets from the Science Based Targets initiative (SBTi).
This furthers the company's progress toward its goal to reach net zero GHG emissions across its value chain by FY 2050.
Gaining approval of near- and long-term targets and a net-zero target from SBTi supports BD's sustainability journey by ensuring that its climate actions are science-based, transparent and aligned with global efforts to combat climate change. In FY 2023, the company reported an 18% reduction of Scope 1 and 2 GHG emissions from a FY 2019 baseline, surpassing its target of 13% for the year.
In addition, BD doubled the number of sites that are now using Green Electric Power and on-site renewables in the form of solar power since FY 2019.
"We're proud of the work we've done this past year to exceed our goals and address our environmental footprint, while also addressing the climate footprint of the healthcare industry, which is equivalent to nearly 5 percent of global emissions," said Maureen Mazurek, chief sustainability and EHS officer, in a statement. "We know that we can't do it alone, and collaboration across industry is what will move the needle. This is why we are actively partnering with suppliers and customers, as well as alliances like Race to Zero and CHARME, to further our goal together."
BD signed the White House HHS Health Sector Climate Pledge and committed to lower its Scope 1 and 2 GHG reduction target by 50% by 2030 from an absolute 2019 baseline.
The company’s emissions reduction goals, as well as other achievements across the company's 2030+ corporate sustainability goals, are reported in the Fiscal Year 2023 "Together We Advance" Corporate Sustainability Report.
Read These Related Articles:
Stay Up-To-Date
